Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026
Key Highlights
- ➤Novavax (NVAX) will report Q3 2026 results before U.S. markets open November 5, 2026
- ➤Management will host an 8:30 a.m. ET webcast and conference call after the release
- ➤Novavax's strategy centers on technology partnerships, capital-efficient R&D, and lean operations
Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026 PR Newswire
GAITHERSBURG, Md., Oct. 29, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its third quarter 2026 financial results before the open of the U.S. financial markets on Thursday, November 5, 2026. Following the release, Company management will host a webcast and conference call at 8:30 a.m. Eastern Time (ET) to discuss financial results and operational highlights. Conference call details: Date: November 5, 2026 Time: 8:30 a.m. ET URL to register phone: Register Here Dial-in number: (+1) 888-880-3330 (U.S.) or (+1) 646-357-8766 (International) Webcast: The live webcast can be accessed at ir.novavax.com/events
Get started
Create a free account to read the full story.